Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sentiss Pharma, formerly known as Promed Exports, is a specialty pharmaceutical company that focuses on the development and manufacturing of high-quality sterile products in the Ophthalmic, ENT, and Inhalation segments. Established in 1990, the company has grown into a global player with a strong presence in Russia, the CIS region, Europe, and India. Sentiss operates a state-of-the-art manufacturing facility in Nalagarh, India, which is equipped with advanced Blow-Fill-Seal technology and adheres to international quality standards. Their extensive product portfolio includes treatments for glaucoma, dry eye, ocular infections, and respiratory conditions. The company is recognized for its expertise in complex generic formulations and its commitment to providing affordable healthcare solutions worldwide. Sentiss continues to expand its global footprint through strategic partnerships and a robust pipeline of value-added medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Promed Exports.